CI
Cytokinetics Incorporated
CYTK· Health Care· BiotechnologyS&P 400
Close · 13/11/2026
56.13
1D
-0.05%52-week range
53.55 – 88.31
Volume
10,14,600.00
Price history
CYTK
15/10/2026 to 13/11/2026
O 56.55 H 56.66 L 55.15
1W+4.54%
1M-12.19%
3M-26.02%
6M-26.00%
1Y-14.88%
3Y+61.48%
5Y+36.57%
MAX+78.30%
Fundamentals
as of 13/11/2026- Market cap
- $7.82B
- Shares out
- 139.30M
- P/E (forward)
- -13.26
- EPS (trailing)
- -5.58
- Dividend yield
- 0.00%
- Beta
- 0.47
- Profit margin
- -686.63%
- P/B
- -24.33
SEC financial statements
57 quarterly and 27 annual periods through 30/09/2026.
Details
- Ticker
- CYTK
- Index
- SP400
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 13/11/2026.
Tracked by Congress
2 filers · 0 on watchlist · 4 buys · 1 sell · D: 3 · R: 2
- 29/09/2026Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 30/06/2026Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 09/10/2025Gilbert CisnerosBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 17/06/2025Lisa McClainSellCytokinetics, Incorporated - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainBuyCytokinetics, Incorporated - Common Stock$1,001–$15,000